The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Artificial Intelligence In Oncology Market In 2026, And How Will Its Value Evolve By 2030?
The market for artificial intelligence in oncology has experienced rapid expansion over recent years. This market is projected to expand from $2.35 billion in 2025 to $3.13 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 33.4%. Historically, this growth can be attributed to several factors including an increase in global cancer incidence rates, the proliferation of oncology research initiatives, wider adoption of digital pathology, the growing application of data-driven cancer diagnostics, and significant investments in advanced oncology infrastructure.
The artificial intelligence in oncology market size is projected to experience substantial growth over the coming years. This market is set to reach $10.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 34.5%. This anticipated expansion during the forecast period stems from factors such as the increasing uptake of precision oncology solutions, the growing need for personalized cancer therapies, the broadened application of AI in clinical oncology trials, the deeper integration of genomics with AI platforms, and a rise in investments directed towards oncology-focused AI startups. Key developments expected during this period involve a greater acceptance of AI-based tools for cancer detection, more frequent utilization of AI in optimizing treatment plans, an expanding integration of AI into drug discovery and development processes, the wider application of predictive oncology analytics, and a heightened emphasis on precision oncology applications.
Access Your Free Sample Report For In-Depth Market Analysis:
What Significant Factors Are Influencing The Artificial Intelligence In Oncology Market Expansion?
The increasing prevalence of cancer diagnoses is projected to stimulate the expansion of the AI in oncology market moving forward. Cancer is a complex condition defined by the uncontrolled multiplication and division of abnormal cells within the body. The adoption of AI in oncology holds the potential to revolutionize patient care by enhancing its precision, personalization, and efficiency. As an illustration, in 2023, a report by the American Cancer Society Inc., a US-based voluntary health organization, showed that the estimated number of new cancer cases climbed from 1.8 million to 1.9 million. This upward trend in cancer incidence is consequently propelling the growth of the AI in oncology market.
How Are Segments Identified Within The Artificial Intelligence In Oncology Market Segment Framework?
The artificial intelligence in oncology market covered in this report is segmented –
1) By Component: Software Solutions, Hardware, Services
2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types
3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types
4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications
5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users
Subsegments:
1) By Software Solutions: Diagnostic Software, Treatment Planning Software, Patient Management Software, Data Analytics Platforms
2) By Hardware: AI-Enabled Imaging Devices, High-Performance Computing Systems
3) By Services: Consulting Services, Integration Services, Maintenance And Support Services
What Trends Are Affecting The Direction Of The Artificial Intelligence In Oncology Market?
Key companies operating within the AI in the oncology market are prioritizing the creation of cutting-edge software, such as cloud-based platforms, to improve their efficiency and offer superior solutions. Cloud-based software is vital for AI applications in oncology, serving as a scalable, adaptable, and easily accessible platform for processing and analyzing extensive medical datasets. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, unveiled Connected Insights, a new cloud-based software specifically for tertiary analysis in oncology applications. By integrating external knowledge bases, Connected Insights streamlines the interpretation and reporting of results from various assay types, empowering labs to expand their utilization of NGS (Next-Generation Sequencing) and significantly reduce the turnaround time for clinical reporting.
Who Are The Companies Competing Within The Artificial Intelligence In Oncology Market?
Major companies operating in the artificial intelligence in oncology market are Azra AI, IBM Corporation, Siemens Healthcare GmbH, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd, Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Proscia Inc., Deep 6 AI Inc., Intel Corporation, Zebra Medical Vision, Ibex Medical Analytics, Nanox Imaging Ltd., Berg LLC
Get The Full Artificial Intelligence In Oncology Market Report:
Which Geographic Region Dominates The Artificial Intelligence In Oncology Market?
North America was the largest region in the AI in oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Artificial Intelligence In Oncology Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Artificial Intelligence In Oncology Market 2026, By The Business Research Company
Ai In Cancer Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report
Artificial Intelligence In Cancer Diagnostics Market Report 2026
Artificial Intelligence In Medicine Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model